Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tolimidone by Melior Pharmaceuticals I for Type 2 Diabetes: Likelihood of Approval
Tolimidone is under clinical development by Melior Pharmaceuticals I and currently in Phase II for Type 2 Diabetes. According to...